AMANDA TULLY: Open Payments
NPI 1790395069 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 53 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $229 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $250 |
| Otsuka America Pharmaceutical, Inc. | 9 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $136 |
| Gilead Sciences, Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 3 | $48 |
| Alkermes, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, CAPLYTA, MAVYRET, UZEDY, COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across WV — which companies pay providers there.
